Gary K. Schwartz

Also affiliated with University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, New York Oncology Hematology, Cancer Research Center, Case Comprehensive Cancer Center, New York University, Case Western Reserve University, Columbia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.1Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9

Top 16%

1.3DataRank

Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

Papers

Driven by 51 papers — median percentile 74. Top paper: “Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium”.

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

5.2DataRank · unranked

198 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

New England Journal of Medicine(2023)10.1056/nejmoa2303383

N/A

3.3DataRank · unranked

158 citations

Elad Sharon, Geraldine O’Sullivan Coyne, Nancy Moore, Jared C. Foster, James Hu +26 more

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

Cancer Cell(2023)10.1016/j.ccell.2023.05.014

N/A

1.8DataRank · unranked

96 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Joanna Poźniak, Shivem B. Shah +28 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9

Top 16%

1.3DataRank

Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djz245

N/A

0.817DataRank · unranked

231 citations

Robert J. Gray, Alice P. Chen, Shuli Li, David R. Patton, Stanley R. Hamilton +35 more

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Cell(2022)10.1016/j.cell.2022.06.007

N/A

0.807DataRank · unranked

216 citations

Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay Caprio, Alcida Karz +54 more

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Melanoma Research(2020)10.1097/cmr.0000000000000701

N/A

0.757DataRank · unranked

14 citations

Oliver Surriga, Daniel J. Olson, Jacob B. Allred, Carrie Strand, Yuanyuan Zha +11 more

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0941

N/A

0.740DataRank · unranked

138 citations

Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu +40 more

Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0066

N/A

0.689DataRank · unranked

15 citations

Xiao Chen, Xinjing Xu, John T. McGuire, Matthew Ingham, Chao Lü +2 more

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion

Journal of Experimental & Clinical Cancer Research(2021)10.1186/s13046-021-01865-2

N/A

0.633DataRank · unranked

67 citations

Yi‐Shing Lisa Cheng, Matthen Mathew, Angela J. Yoon, Gary K. Schwartz, Shashi Bala +3 more

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer

Cell Reports(2023)10.1016/j.celrep.2023.113198

N/A

0.612DataRank · unranked

58 citations

Jessica Armand, Anton Safonov, Mimi Zhang, Rajesh K. Soni, Gary K. Schwartz +7 more

A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11511

N/A

0.590DataRank · unranked

50 citations

Michelle R. Mahoney, Suzanne George, Cristina R. Antonescu, David A. Liebner, Brian Andrew Van Tine +6 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506

N/A

0.553DataRank · unranked

11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers

Cancers(2020)10.3390/cancers12071768

N/A

0.542DataRank · unranked

36 citations

Ajaykumar C. Morani, Najat C. Daw, Salah-Eddine Lamhamedi-Cherradi, Vivek Subbiah, Brian A. Menegaz +22 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0.542DataRank · unranked

36 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)

Cancer(2023)10.1002/cncr.35103

N/A

0.481DataRank · unranked

12 citations

Nathan R. Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R. Antonescu, Gary Patrick Frenette +4 more

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3817

N/A

0.477DataRank · unranked

23 citations

Rachel S. Heise, Kristen Ganjoo, Elizabeth J. Davis, Suzanne George, Melissa Burgess +16 more

Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2258

N/A

0.464DataRank · unranked

21 citations

Alexandria Yao, Daria Vasilyeva, Nicole Kaplan, Austin Shackelford, Angela J. Yoon +6 more

Randomized phase II study of sorafenib with or without everolimus in patients with radioactive iodine refractory Hürthle cell thyroid cancer (HCC) (Alliance A091302/ ITOG 1706).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6076

N/A

0.396DataRank · unranked

13 citations

Nathan R. Foster, Yungpo Bernard Su, Ardaman Shergill, Alan L. Ho, Bhavana Konda +4 more

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.42046

N/A

0.373DataRank · unranked

11 citations

Tianyi Sun, David D. Chism, Narjust Duma, Julie Fu, Na Tosha Gatson +87 more

The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485049

N/A

0.360DataRank · unranked

10 citations

Johannes C. Melms, Meri Rogava, Chris J. Frangieh, Shivem B. Shah, Zachary Walsh +21 more

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.03.462951

N/A

0.312DataRank · unranked

7 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +48 more

A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps11578

N/A

0.292DataRank · unranked

6 citations

Shing Mirn Lee, Mia C. Weiss, Brittany L. Siontis, Benjamin Powers, Warren Chow +6 more

Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma

Current Treatment Options in Oncology(2025)10.1007/s11864-025-01349-x

N/A

0.292DataRank · unranked

6 citations

Elizabeth Nowak, Jarrell Imamura, Jessica Leng, Dale Shepard, Shauna R. Campbell +6 more

Down-regulation of tumor suppressor miR-34a contributes to head and neck cancer by up-regulating MET oncogene and modulating tumor immune evasion

Research Square(2020)10.21203/rs.3.rs-63977/v1

N/A

0.269DataRank · unranked

5 citations

Yi‐Shing Lisa Cheng, Matthen Mathew, Angela J. Yoon, Gary K. Schwartz, Shashi Bala +3 more

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Cancers(2022)10.3390/cancers14174334

N/A

0.269DataRank · unranked

5 citations

Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann +42 more

Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7018

N/A

0.269DataRank · unranked

5 citations

Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears +15 more

Multi-modal single-cell and whole-genome sequencing of minute, frozen specimens to propel clinical applications

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.13.480272

N/A

0.208DataRank · unranked

3 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Patricia Ho +15 more

Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017

Cancer(2023)10.1002/cncr.35078

Top 67%

0.171DataRank

Top 67%2 citations

Shaylene McCue, Jun He, Jacqueline M. Lafky, Lisa A. Carey, Evanthia Galanis +9 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8603

N/A

0.104DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Panos Savvides, Liza C. Villaruz, Patrick M. Forde +12 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps8598

N/A

0.104DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Vinicius Ernani, Patrick M. Forde, Liza C. Villaruz +12 more

Data from Overexpression of DDX43 Mediates MEK Inhibitor Resistance through RAS Upregulation in Uveal Melanoma Cells

10.1158/1535-7163.c.6536485

N/A

0DataRank · unranked

0 citations

Raya Khanin, Richard D. Carvajal, Gary K. Schwartz, Grazia Ambrosini

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

Phase II trial of pegylated arginine deiminase in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11508

N/A

0DataRank · unranked

9 citations

Angela C. Hirbe, Jingqin Luo, Peter John Oppelt, Mia C. Weiss, Vanessa Eulo +14 more

Dose-finding designs for trials of molecularly targeted agents and immunotherapies

UNC Libraries(2020)10.17615/97xj-4d96

N/A

0DataRank · unranked

0 citations

Anastasia Ivanova, Jonathan Shtaynberger, Jimmy Duong, Gulam A. Manji, Chiuzan, Cody +2 more

NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11521

N/A

0DataRank · unranked

2 citations

Pedro A. Torres‐Saavedra, Brian Andrew Van Tine, David G. Kirsch, Michelle A. Rudek, Paul E. Wakely +13 more

Multi-modal single-cell profiling of sarcomas from archival tissue reveals mechanisms of resistance to immune checkpoint inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e23518

N/A

0DataRank · unranked

0 citations

Sminu Bose, Amit Dipak Amin, Somnath Tagore, Johannes C. Melms, Simon Berhe +4 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570

N/A

0DataRank · unranked

6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11562

N/A

0DataRank · unranked

7 citations

Michelle R. Mahoney, Fabrizio Remotti, Ardaman Shergill, Mark A. Dickson, Richard F. Riedel +10 more

Therapeutic advances in leiomyosarcoma

Frontiers in Oncology(2023)10.3389/fonc.2023.1149106

N/A

0DataRank · unranked

49 citations

Sminu Bose, Matthew Ingham, Gary K. Schwartz, Kristine Peregrino Lacuna

The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0399

N/A

0DataRank · unranked

18 citations

Christopher A. Natale, Elgilda Musi, Tina Garyantes, Gary K. Schwartz, Grazia Ambrosini

Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11584

N/A

0DataRank · unranked

2 citations

Sumithra J. Mandrekar, Jacob B. Allred, Stephanie Berg, Martee L. Hensley, Brian Andrew Van Tine +4 more

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11531

N/A

0DataRank · unranked

1 citations

Shing M. Lee, Liner Ge, Mihaela Druta, Anthony P. Conley, Mary Louise Keohan +14 more

Data from Imaging Colon Cancer Response Following Treatment with AZD1152: A Preclinical Analysis of [18F]Fluoro-2-deoxyglucose and 3′-deoxy-3′-[18F]Fluorothymidine Imaging

(2023)10.1158/1078-0432.c.6520382

N/A

0DataRank · unranked

0 citations

Tatiana Kochetkov, Shangde Cai, Jiyuan Wu, Mikhail Shamis, Jayasree Nair +7 more

Novel trial designs for patients with gastrointestinal stromal tumor

ESMO Open(2024)10.1016/j.esmoop.2023.102218

N/A

0DataRank · unranked

3 citations

S. Rothschild, Guillermo Villacampa, Michael C. Heinrich, Sally L. George, Jean‐Yves Blay +10 more

Single Nuclei-Derived Molecular Subtypes of Gastrointestinal Stromal Tumors Correlate with Clinicopathologic Features and Predict Clinical Outcomes

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.21.647322

N/A

0DataRank · unranked

0 citations

Alexander T. Wenzel, John Y. Jun, Diwakar Guragain, Chih‐Min Tang, Mark Antkowiak +19 more

Systematic elucidation and pharmacologic targeting of non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.12.681609

N/A

0DataRank · unranked

0 citations

Adina Grunn, Arsenije Kojadinovic, Charles Karan, Ronald Realubit, Cristina I. Caescu +9 more

Gary K. Schwartz

Indexed papers

Top data-sharing exemplar

Papers